Blueprint Medicines Corp. is a company in the U.S. stock market and it is a holding in 84 U.S.-traded ETFs. BPMC has around 5.5M shares in the U.S. ETF market. The largest ETF holder of BPMC is the iShares Russell 2000 ETF (IWM), with approximately 1.32M shares. Investors may also find of interest that the ETF with the largest allocation to BPMC stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 3.84%. On average, U.S. ETFs allocate 0.36% of BPMC to their portfolios.
Additionally, BPMC is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BPMC as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.